Adenocarcinoma Lung Stage IV
1 clinical trials · Condition
◉ Watch Adenocarcinoma Lung Stage IV
| Record | Firm | Date |
|---|---|---|
| Poziotinib in Stage IV Lung Adenocarcinoma With HER2 Mutation (KASTT001) (NCT02979821) | Korean Association for the Study of Targeted Therapy | 2016-10-01 |
Track Adenocarcinoma Lung Stage IV automatically
Every clearance here is in the API, with alerts when new ones post.